Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01719250
Title Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mayo Clinic
Indications

diffuse large B-cell lymphoma

follicular lymphoma

mantle cell lymphoma

non-Hodgkin lymphoma

Therapies

Buparlisib

Age Groups: adult
Covered Countries USA


No variant requirements are available.